Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Overseas businesses. The Domestic Business covers the manufacturing, research, and development operations in Japan. The Overseas business comprises of sales and production in Europe, Taiwan and China. The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo, Japan.

Visterra, Inc. engages in pharmaceutical drug research and development of therapeutic and diagnostic products for infectious diseases. It also provides structure-based design of therapeutics and diagnostic platforms, based on an understanding of glycobiology and glycochemistry. The company was formerly known as Parasol Therapeutics, Inc. and changed its name in May 2010. Visterra, Inc. was founded in 2007 and is based in Cambridge, Massachusetts.

Sanofi Pasteur SA develops, manufactures, and supplies vaccines in France and internationally. The company provides vaccines for bacterial and viral diseases, including pertussis, diphtheria, typhoid fever, poliomyelitis, influenza, and mumps. It has production sites in France, the United States, Canada, China, Thailand, and Argentina. The company was formerly known as Aventis Pasteur S.A. and changed its name to Sanofi Pasteur SA in 2004. The company was founded in 1990 and is headquartered in Lyon, France. The company is headquartered in Lyon, France. Sanofi Pasteur SA operates as a subsidiary of Sanofi-Aventis.

Located in San Diego County, California, an area well known for biotechnology and scientific discovery, CTK Biotech develops and manufactures innovative immunodiagnostic tools and point of care diagnostic test kits for the IVD community worldwide. Their IVD products allow medical professionals to quickly and accurately diagnose disease and meet patient needs. The simplicity and portability of their test kits make them ideally suited for use in a wide range of settings including remote locations and countries with large populations where complicated medical diagnostics are not readily available.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Novartis Pharma GmbH engages in the production and sale of pharmaceutical products. The firm establishes and operates institutes for the development of medicinal products. It also conducts research and development in the field of pharmacy. The company was founded by Johann Rudolf Geigy-Gemuseus in 1758 and is headquartered in Vienna, Austria.

Beijing Jiannaixi Biotechnology Co., Ltd., established on 2008-07-21, Business scope includes general items:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Sales of Class II Medical Devices;Chemical product sales(No licensed chemical products);Engineering and Technology Research and Experimental Development;Medical Research and Experimental Development;Natural science research and experimental development;Import and export.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Production of Class III Medical Devices;Class III medical device business;Production of Class II Medical Devices;road freight transport(Does not contain dangerous goods);road freight transport(Web Freight).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)(Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

GenBody, Inc. engages in developing raw materials for diagnostic use such as ELISA and rapid diagnostic tests. The company was founded by Jeong Jeom-Gyu on October 17, 2012 and is headquartered in Cheonan, South Korea.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Shenzhen Jiyin Biotechnology Co. Ltd. is a company headquartered in China that engages in R & D biotechnology.

Jilin Shuangzheng Medical Technology Co., Ltd., established on 2013-03-27, Business scope includes biomedical technology research and development and consulting services,technical consulting,technology transfer;medical instruments,Green facilities,computer,Sales and maintenance of printers and consumables;Medical device production;import and export trade(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments).

Beijing Zhuangdi Haohe Biomedical Technology Co., Ltd., established on 2000-12-07, Business scope includes biomedical technology development,Serve,consult;Sales of chemical products(Does not contain dangerous chemicals and a class of precursor chemicals),medical instruments(Class I,Class II).(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)

LumiraDx UK Ltd., part of LumiraDX Ltd., is a British company located in London that develops portable diagnostic instrument and platform for community-based healthcare. The firm was founded in 2014 by Jerome Francis McAleer and Ronald Zwanziger. Ronald Zwanziger has been the CEO since the company founding. LumiraDx UK Ltd. was acquired by CA Healthcare Acquisition Corp. on September 28, 2021 for $2,537.21 million.\nThe company says this about itself: LumiraDx is a next-generation point of care diagnostics company that is transforming community-based healthcare. Founded in 2014, the company manufactures and commercializes an innovative diagnostic Platform that supports a broad menu of tests with lab comparable performance at the point of care. LumiraDx's diagnostic testing solutions are being deployed by governments and leading healthcare institutions across laboratories, urgent care, physician offices, pharmacy, schools, and workplaces to screen, diagnose and monitor wellness as well as disease. The company has on the market and in development 30+ tests covering infectious diseases, cardiovascular disease, diabetes and coagulation disorders, all on the LumiraDx Platform. In addition, the company has a comprehensive portfolio of fast, accurate and cost-efficient COVID-19 testing solutions from the lab to point of need. Based in the UK with more than 1500 employees worldwide, LumiraDx is supported by institutional and strategic investors including the Bill & Melinda Gates Foundation, Morningside Ventures, U.S. Boston Capital Corporation, and Petrichor Healthcare Capital Management.

Suzhou Novi Biotech Co., Ltd., established on 2019-07-22, The scope of business includes engaging in technology development in the field of biotechnology,technical consulting,Technology Transfer and Technical Services;Bioassay Technology Development;research and development,Sales:medical instruments,Electronic equipment;Sales:Health Supplies,beauty products.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Shanxi Ruihao Biotechnology Co., Ltd., established on 2013-03-29, Business scope includes biological products(No vaccine)technology development,technology transfer,Technical Consulting and Technical Services;Medical device production(Operate under license:2002CategoriesIIkind:6822-4-Ophthalmic Optical Instruments, 6826-3-Spectral Radiation Therapy Instruments,6840-In vitro diagnostic reagents);Sales of Medical Devices;Import and export business of the above business items(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Part of Southern Medical University, Zhujiang Hospital of Southern Medical University is a company headquartered in Guangzhou, China, that operates hospital.